The competitive landscape in the AI medical industry is undergoing a critical turning point. On June 9, iflytek Healthcare officially launched the Spark Medical Large Model V3.5, which was trained on a fully domestic computing power foundation. Unlike previous industry trends that focused solely on the scale of parameters, this new model has targeted two core application scenarios: clinical diagnosis and treatment, as well as resident health management. Based on actual data from the implementation in top-tier tertiary hospitals, it declares that it has crossed the practical threshold from the laboratory to clinical settings.

As artificial intelligence becomes deeply integrated with the healthcare industry, the market is entering a period of rapid growth. Relevant data shows that the scale of the domestic AI healthcare market has exceeded 100 billion yuan by 2025, and it is expected to exceed 150 billion yuan in 2026, maintaining a strong annual compound growth rate of 30%. Industry analysis generally believes that 2026 will be the "definite year" for the commercialization of AI healthcare.

In this round of technological competition, industry consensus is also changing subtly. Diverse opinions point out that the pure parameter race is no longer the only standard for evaluating the quality of models. The core competitiveness is now shifting toward high-quality, exclusive medical data and deep adaptation to business scenarios. After all, the essential nature of the medical scenario determines the final choice of the payers—those who can truly solve the "pain points" of clinical doctors and successfully complete the "last mile" of transforming technology into medical productivity will be able to take the initiative in the market.

This upgrade of the Spark Medical Large Model V3.5 is the result of iflytek Healthcare's in-depth efforts in vertical fields. By achieving breakthroughs from 0 to 1 in areas such as medical voice interaction and automated medical record generation, the model has not only delivered a satisfactory performance in technical evaluations but also demonstrated its leading advantages in large-scale applications through real-world hospital operations, setting a new benchmark for "practical" AI healthcare.